CRO Valuation

Healthcare & Life Sciences
Pharma Services Company Valuation: What Are CROs and CDMOs Worth?
ByAuxo Capital AdvisorsJune 19, 2026June 20, 2026
A buyer-focused guide to pharma services company valuation covering normalized EBITDA, CRO and CDMO business-model differences, backlog, sponsor quality, capacity, capex, valuation methods, deal structure, and seller proceeds.
Read More Pharma Services Company Valuation: What Are CROs and CDMOs Worth?
Healthcare & Life Sciences
CRO M&A: How Buyers Underwrite Contract Research Organizations
ByAuxo Capital AdvisorsJune 19, 2026
A buyer-focused guide to CRO M&A valuation, showing how acquirers translate backlog quality, project visibility, sponsor concentration, scientific talent, and diligence findings into multiples, deal terms, and purchase price adjustments.
Read More CRO M&A: How Buyers Underwrite Contract Research Organizations